Bioreset Medical — North Palm Beach, Florida

Bioreset Medical is a clinical research site located in North Palm Beach, Florida, United States 33408.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Bioreset Medical has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Osteoarthritis (OA), Longevity, Wound Care.

Sponsors: MuseCell Innovations Pte LTD.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in North Palm Beach

Browse all research sites in Florida · View every site in North Palm Beach

• Allergy Associates of the Palm Beaches
• Laszlo J. Mate, M.D., P.A.
• Allergy Associates of the Palm Beaches PA
• Laszlo J Mate, MD, PA
• Laszlo J. Mate, MD
• Research Site
• Novartis Investigative Site
• NeurogesX Investigational Site
• Contact CSL Behring for facility details
• US172
• Octapharma Research Site
• GSK Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Bioreset Medical?

Bioreset Medical has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Bioreset Medical conducted?

Bioreset Medical has 1 clinical trials on record, with 1 currently active. Their work covers Osteoarthritis (OA), Longevity, Wound Care.

Is Bioreset Medical accredited by Crixeo Clinical Trials?

Bioreset Medical has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Bioreset Medical?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.